Zebra Capital Management LLC Myriad Genetics Inc Transaction History

Zebra Capital Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$16.45 - $25.88 $22,388 - $35,222	1,361 Added 9.73%	15,352 $279,000
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $4,942 - $6,106	-218 Reduced 1.53%	13,991 $353,000
Q4 2021 Feb 14, 2022	SELL	$24.13 - $32.63 $126,417 - $170,948	-5,239 Reduced 26.94%	14,209 $392,000
Q3 2021 Nov 15, 2021	SELL	$29.97 - $36.66 $311,358 - $380,860	-10,389 Reduced 34.82%	19,448 $628,000
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $81,831 - $105,102	-3,223 Reduced 9.75%	29,837 $912,000
Q1 2021 May 17, 2021	BUY	$19.92 - $31.6 $658,555 - $1.04 Million	33,060 New	33,060 $1.01 Million
Q4 2018 Feb 14, 2019	SELL	$27.23 - $45.56 $118,750 - $198,687	-4,361 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $163,842 - $219,532	4,361 New	4,361 $201,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $339,882 - $492,002	-12,248 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $112,033 - $159,364	3,886 Added 46.47%	12,248 $362,000
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $47,596 - $62,135	-1,673 Reduced 16.67%	8,362 $287,000
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $240,940 - $363,267	10,035	10,035 $363,000

246

91.4M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.04B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Zebra Capital Management LLC with notifications on news.